198 related articles for article (PubMed ID: 30473182)
1. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
[TBL] [Abstract][Full Text] [Related]
2. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
3. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
[TBL] [Abstract][Full Text] [Related]
4. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C
Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497
[TBL] [Abstract][Full Text] [Related]
5. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
Wei H; Yu K; Liu Y; Li L; Wang G
BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.
Grimm M; Krimmel M; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Polligkeit J; Reinert S; Hoefert S
Clin Oral Investig; 2013 Apr; 17(3):949-55. PubMed ID: 22782258
[TBL] [Abstract][Full Text] [Related]
7. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
8. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
9. Upregulated LOX and increased collagen content associated with aggressive clinicopathological features and unfavorable outcome in oral squamous cell carcinoma.
Yu M; Shen W; Shi X; Wang Q; Zhu L; Xu X; Yu J; Liu L
J Cell Biochem; 2019 Sep; 120(9):14348-14359. PubMed ID: 31140650
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.
Wang Y; Zhang X; Zhang Y; Zhu Y; Yuan C; Qi B; Zhang W; Wang D; Ding X; Wu H; Cheng J
Cancer Biol Ther; 2015; 16(6):839-45. PubMed ID: 25970228
[TBL] [Abstract][Full Text] [Related]
11. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
13. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma.
Li Z; Yan T; Wu X; Zhang W; Li J; Wang L; Yang J
J Oral Pathol Med; 2020 Nov; 49(10):1030-1036. PubMed ID: 32808339
[TBL] [Abstract][Full Text] [Related]
15. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
17. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.
Grimm M; Lazariotou M
Med Oncol; 2012 Sep; 29(3):1435-47. PubMed ID: 21853343
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
[TBL] [Abstract][Full Text] [Related]
20. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]